The Mosaic Neo mitral bioprosthesis can be implanted through sternotomy, minimally invasive cardiac surgery or robotic access. 

The 22-week-old patient was successfully treated by a traveling cardiologist—all without being transported to the cath lab.

The Society of Thoracic Surgeons put together an expert committee to examine the prevention and treatment of new-onset postoperative atrial fibrillation after cardiac surgery. The group shared recommendations for before, during and after treatment.

The new device from Arizona-based Corvention was built to withstand the extreme pressures associated with treating severely calcified valves. 

Performing TAVR on a patient with bicuspid AS can be challenging. Transcatheter aortic root tricuspidization may represent a new treatment strategy for these patients, according to a new first-in-human trial.

Short-term outcomes were comparable, but long-term data revealed a significant difference in all-cause mortality.

When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival. 

Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.

The TRiCares Topaz uses a unique two-stent frame valve prosthesis for better sealing and flexibility.